Eli Lilly and Company · 2 days ago
Director / Senior Director Clinical Imaging Research Scientist
Eli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. The Senior Director - Clinical Imaging Research Scientist role involves providing strategic and technical input on imaging biomarkers and image analysis techniques in clinical development, with a focus on therapeutic areas such as Oncology, Diabetes, Immunology, and Neurodegeneration.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Provide strategic and technical input on the development, implementation and evaluation of imaging biomarkers and image analysis techniques in various phases of clinical development across therapeutic areas such as Oncology, Diabetes, Immunology, and Neurodegeneration
Analyze molecular imaging data obtained within targeted radionuclide therapy studies to locate tumors, assess tracer biodistribution for personalized dosimetry and treatment planning, and evaluate treatment efficacy through follow-up imaging
Design and implement customized imaging programs in clinical trials and image analysis methods, leveraging novel and standard methodologies
Lead cross-functional projects with internal research and clinical (medical, operations, statistics, regulatory) teams
Develop and maintain productive external partnerships (Contract Research Organizations, software developers, scanner manufacturers, academic institutions) to support the validation of clinical imaging instrumentation and its application in therapeutic development
Evaluate key scientific developments in clinical image analysis and implement emerging technologies including modeling and artificial intelligence
Develop, validate, and implement image analysis methodologies and software tools for quantitative clinical image analyses as well as analyze clinical images from various modalities, such as PET, SPECT, CT, and MRI
Author and review clinical trial documents (protocols, study reports, and technical manuals)
Communicate, present, and publish conference abstracts and manuscripts
Qualification
Required
PhD or MD with a specialization in Medical Imaging, Biomedical Engineering, Computational Biology or other image analysis related discipline with minimum of 5 years of professional experience in clinical imaging applications
Preferred
Evidence of your direct role and contribution to the medical image analysis in targeted radionuclide therapy studies (publications in peer-reviewed scientific journals, presentations at conferences and/or developed software codes)
Knowledge of both physiological and instrumental factors that may affect quantitative accuracy of clinical imaging procedures in oncology, especially in targeted radionuclide therapies
Strong technical understanding of SPECT, PET, CT, and MR image acquisition, reconstruction, processing, quantitative analyses, and interpretations for therapeutic applications
Participation in clinical trials and implementation of imaging biomarkers
Proven expertise in programming, developing and customizing image analysis software codes
Proven leadership, organizational, and communication skills
Benefits
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
Recent News
2026-01-06
2026-01-06
Company data provided by crunchbase